Galileo - Biotech Innovation Fund BC USD

The Galileo – Biotech Innovation Fund is an actively managed equity fund that primarily invests over half of its assets in biotechnology companies, ensuring a strong focus on this sector. The remaining assets, up to 49%, are allocated to liquid investments such as shares, bonds, money market instruments, certificates, and various structured products. The fund manager continuously reviews and adjusts the portfolio based on market conditions, and may also use derivatives to enhance or protect the investments. This strategic approach aims to achieve significant growth by leveraging opportunities within the biotech industry and complementary financial instruments.